Patents Assigned to Everyoung Technologies, Inc.
  • Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
    Patent number: 6187750
    Abstract: A method for treating patients having symptoms consistent with multiple sclerosis comprising administering a regimen of doses of human growth hormone of less than 0.5 mg/day. In one aspect, the method includes replenishing one or more of melatonin, thymus, thyroid, adrenal and sex hormones to predetermined levels in conjunction with the human growth hormone.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: February 13, 2001
    Assignee: Everyoung Technologies, Inc.
    Inventor: Edmund Y. M. Chein